March 2019 Corporate Presentation
FNN - Shaw & Partners Investor Event 26.2.19
St Vincent's Hospital Principal Investigator Discussed LuPIN-1 Study
FNN interview with Nox Chief Medical Officer on Interim Data
Principal Investigator Discusses LuPIN-1 Study
2018 Annual General Meeting podcast
NOX 2018 AGM Presentations
Noxopharm Releases Latest Corporate Presentation
Noxopharm (ASX:NOX) Presentation, FNN Investor Event, 15 Aug 2018, Sydney
Noxopharm (ASX:NOX) update on NOX66 and radiotherapy trials